Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05916378

Enrollment

514

Registered

2023-06-23

Start date

2023-05-22

Completion date

2026-04-21

Last updated

2026-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Genomic Testing, Precision Breast Cancer Care, Precision Medicine

Brief summary

The purpose of this study is to identify the barriers, and the extent of said barriers, to genomic testing for breast cancer patients among low-income and minority populations, particularly throughout Northern California. The investigators have created a survey that is available online for any patient with cancer to fill out voluntarily regarding their experiences to date. The survey is available at: https://stanforduniversity.qualtrics.com/jfe/form/SV\_7VElf8oesWcB3bE

Detailed description

The study has two main data-collecting phases. In phase 1, the investigators will engage multilevel stakeholders to respond to a survey assessing experience with and perceptions of genomic testing and its accessibility for patients with breast cancer in California. In phase 2, selected and interested survey participants who voluntarily provide their contact information on the survey will be asked to participate in an in-depth 1:1 semi-structured interview to explore disparities in genomic testing for breast cancer more closely. The investigators will then utilize their findings from both phases to present aggregate findings to an Expert Panel and Community Advisory Board and work together to develop policy recommendations. The policy recommendations will then be presented to policy makers, with the aim of identifying sustainable solutions that address breast cancer treatment and outcome disparities throughout Northern California.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

* The patients must be 18 years or older. * Patients who opt in to complete the survey. * Patients must have the capacity to verbally consent for the interview.

Exclusion criteria

* Patients who under the age of 18 years old.

Design outcomes

Primary

Measure	Time frame	Description
Number of participants who fill out the survey and participate in the semi-structured interviews. [ Time Frame: 12 Months ]	12 Months	We will track the number of participants who fill out the survey for the 12 month duration of the study and the number of participants who participate in the semi-structured telephone interviews.

Countries

United States

Outcome results